Xvivo Perfusion Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
25 Nov 24 | SellSEK 915,000 | Christoffer Rosenblad | Individual | 2,000 | SEK 457.50 | |
20 Nov 24 | SellSEK 959,700 | Christoffer Rosenblad | Individual | 2,100 | SEK 457.00 | |
14 Nov 24 | BuySEK 345,750 | Erik Stromqvist | Individual | 750 | SEK 461.00 | |
07 Jun 24 | BuySEK 222,000 | Lars Henriksson | Individual | 500 | SEK 444.00 | |
26 Jan 24 | BuySEK 280,687 | Gosta Johannesson | Individual | 1,000 | SEK 289.37 |
Insider Trading Volume
Insider Buying: 0RKL insiders have sold more shares than they have bought in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 131,860 | 0.419% |
Private Companies | 1,875,000 | 5.95% |
VC/PE Firms | 4,493,504 | 14.3% |
General Public | 10,593,211 | 33.6% |
Institutions | 14,405,895 | 45.7% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
4,493,504 | SEK 2.1b | 0% | 10.58% | |||
2,842,553 | SEK 1.3b | 0% | 0.5% | |||
1,875,000 | SEK 886.9m | 0% | no data | |||
1,673,616 | SEK 791.6m | 6.93% | 0.05% | |||
1,261,000 | SEK 596.5m | 0% | no data | |||
1,189,246 | SEK 562.5m | 0% | 0.07% | |||
1,019,581 | SEK 482.3m | 0% | 0.52% | |||
811,200 | SEK 383.7m | 0% | 0.13% | |||
577,463 | SEK 273.1m | 0% | 0.01% | |||
555,392 | SEK 262.7m | 0% | 0.02% | |||
492,777 | SEK 233.1m | 0% | 4.05% | |||
466,257 | SEK 220.5m | 0% | 0.11% | |||
447,849 | SEK 211.8m | 0% | 0.08% | |||
399,142 | SEK 188.8m | 0% | 0.6% | |||
316,456 | SEK 149.7m | 5.96% | no data | |||
225,000 | SEK 106.4m | 0% | 0.28% | |||
204,078 | SEK 96.5m | 0% | 0.2% | |||
190,534 | SEK 90.1m | -2.45% | 0.02% | |||
166,002 | SEK 78.5m | 0% | 2.82% | |||
159,950 | SEK 75.7m | 19.2% | no data | |||
153,317 | SEK 72.5m | 0% | 0.02% | |||
137,770 | SEK 65.2m | -0.11% | no data | |||
126,266 | SEK 59.7m | 0% | 0.05% | |||
124,300 | SEK 58.8m | 0% | 12.32% | |||
115,000 | SEK 54.4m | 0% | 2.99% |
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 01:28 |
End of Day Share Price | 2024/12/23 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Xvivo Perfusion AB (publ) is covered by 9 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Dylan van Haaften | Bryan Garnier & Co |
Maria Vara Fernández | Bryan Garnier & Co |
Kristofer Liljeberg-Svensson | Carnegie Investment Bank AB |